Erol Onel
Cali Biosciences · Pacira Pharmaceuticals, Inc
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Erol Onel as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:02 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05831449 · CPL-01 in the Management of Postoperative Pain After BunionectomyCali Pharmaceuticals LLC · completed · Bunion, Post-operative Pain · study director
- Ph3NCT05813847 · Herniorrhaphy for Postoperative PainCali Pharmaceuticals LLC · completed · Hernia, Inguinal, Post Operative Pain · study director
- Ph2NCT05411861 · Post-Operative Pain and Opioid Reduction Trial After BunionectomyCali Pharmaceuticals LLC · completed · Hallux Valgus and Bunion · study chair
- Ph2NCT05080959 · A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal HerniorrhaphyCali Pharmaceuticals LLC · completed · Inguinal Herniorrhaphy · study chair
- Ph2NCT04182880 · Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative PainCali Pharmaceuticals LLC · completed · Abdominoplasty · study chair
- Ph4NCT02353754 · Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean SectionPacira Pharmaceuticals, Inc · terminated · Pain · study director
- Ph3NCT01802411 · Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral ThoracotomyPacira Pharmaceuticals, Inc · completed · Posterolateral Thoracotomy, Postoperative Pain · study director
- Ph2/Ph3NCT01683071 · Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee ArthroplastyPacira Pharmaceuticals, Inc · completed · Postoperative Pain · study director
- Ph2NCT00529126 · Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing HemorrhoidectomyPacira Pharmaceuticals, Inc · completed · Postoperative Pain · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:02 UTC. The ranking covers the 200 most relevant of 13 PubMed records, and a shared surname and initials can bring in a namesake. All 13 on PubMed
- Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial.Dis Colon Rectum · 2011273 citationsRCR 11.2
- 233 citationsRCR 11.3
- 207 citationsRCR 9.5
- 123 citationsRCR 6.3
- The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammaplasty: a randomized, double-blind, active-control study.Aesthet Surg J · 201297 citationsRCR 4.9
- The safety of liposome bupivacaine, a novel local analgesic formulation.Clin J Pain · 201474 citationsRCR 3.9
- The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers.Reg Anesth Pain Med · 201257 citationsRCR 3.1
- Bupivacaine extended-release liposome injection exhibits a favorable cardiac safety profile.Reg Anesth Pain Med · 201237 citationsRCR 1.9
- Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers.J Clin Pharmacol · 201229 citationsRCR 1.4
- Time to onset of analgesia following local infiltration of liposome bupivacaine in healthy volunteers: a randomized, single-blind, sequential cohort, crossover study.Int J Clin Pharmacol Ther · 201326 citationsRCR 1.5